Uwe K. Zettl

15.0k total citations
297 papers, 7.2k citations indexed

About

Uwe K. Zettl is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Uwe K. Zettl has authored 297 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Pathology and Forensic Medicine, 91 papers in Neurology and 62 papers in Molecular Biology. Recurrent topics in Uwe K. Zettl's work include Multiple Sclerosis Research Studies (207 papers), Peripheral Neuropathies and Disorders (70 papers) and Polyomavirus and related diseases (31 papers). Uwe K. Zettl is often cited by papers focused on Multiple Sclerosis Research Studies (207 papers), Peripheral Neuropathies and Disorders (70 papers) and Polyomavirus and related diseases (31 papers). Uwe K. Zettl collaborates with scholars based in Germany, Austria and United States. Uwe K. Zettl's co-authors include Michael Hecker, Paulus Rommer, Hans‐Peter Hartung, Alexander Winkelmann, Peter Flachenecker, Eilhard Mix, Robert Patejdl, T. Henze, Brit Fitzner and Dirk Koczan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Uwe K. Zettl

286 papers receiving 7.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe K. Zettl Germany 47 4.1k 2.0k 1.5k 1.4k 927 297 7.2k
Anthony T. Reder United States 48 4.4k 1.1× 1.6k 0.8× 1.5k 1.0× 1.8k 1.3× 1.3k 1.4× 160 7.3k
Rogier Q. Hintzen Netherlands 50 4.2k 1.0× 1.6k 0.8× 1.5k 1.0× 3.2k 2.3× 1.0k 1.1× 160 8.5k
Hayrettin Tumani Germany 50 2.4k 0.6× 2.9k 1.5× 2.1k 1.4× 1.1k 0.8× 843 0.9× 226 8.0k
Jorge Correale Argentina 52 4.0k 1.0× 1.3k 0.7× 2.2k 1.4× 3.4k 2.4× 816 0.9× 226 9.9k
María Trojano Italy 57 8.0k 2.0× 2.9k 1.5× 1.6k 1.1× 1.3k 0.9× 1.7k 1.9× 304 11.3k
Luanne M. Metz Canada 44 6.7k 1.7× 2.4k 1.2× 1.6k 1.0× 1.3k 0.9× 1.6k 1.7× 150 10.4k
Bernd C. Kieseier Germany 58 4.8k 1.2× 4.3k 2.2× 1.9k 1.2× 2.5k 1.8× 1.2k 1.3× 274 11.6k
Manuel Comabella Spain 47 5.0k 1.2× 2.3k 1.2× 2.2k 1.5× 2.0k 1.4× 1.8k 2.0× 202 8.9k
Dennis Bourdette United States 56 3.7k 0.9× 1.5k 0.8× 1.6k 1.1× 2.4k 1.7× 845 0.9× 251 9.2k
Alireza Minagar United States 43 2.3k 0.6× 1.4k 0.7× 1.8k 1.2× 1.0k 0.7× 877 0.9× 261 7.3k

Countries citing papers authored by Uwe K. Zettl

Since Specialization
Citations

This map shows the geographic impact of Uwe K. Zettl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe K. Zettl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe K. Zettl more than expected).

Fields of papers citing papers by Uwe K. Zettl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe K. Zettl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe K. Zettl. The network helps show where Uwe K. Zettl may publish in the future.

Co-authorship network of co-authors of Uwe K. Zettl

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe K. Zettl. A scholar is included among the top collaborators of Uwe K. Zettl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe K. Zettl. Uwe K. Zettl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zettl, Uwe K., Niklas Frahm, & Michael Hecker. (2024). Challenges in monitoring the quality of care in multiple sclerosis. The Lancet Regional Health - Europe. 42. 100950–100950.
2.
3.
Frahm, Niklas, et al.. (2022). Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic. Scientific Reports. 12(1). 15147–15147. 5 indexed citations
4.
Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2022). SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study. The Lancet Regional Health - Europe. 22. 100502–100502. 17 indexed citations
5.
Frahm, Niklas, David Ellenberger, Peter Flachenecker, et al.. (2022). Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry. Neurology and Therapy. 11(1). 319–336. 3 indexed citations
6.
Großmann, Annette, Karlheinz Hauenstein, Marc‐An dré Weber, et al.. (2021). Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients. Neurological Sciences. 43(4). 2631–2639. 4 indexed citations
7.
Blaschke, Stefan, David Ellenberger, Peter Flachenecker, et al.. (2021). Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry. Multiple Sclerosis Journal. 28(6). 865–871. 9 indexed citations
8.
Frahm, Niklas, Jörg Bätzing, David Ellenberger, et al.. (2021). Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis. Therapeutic Advances in Neurological Disorders. 14. 4203329424–4203329424. 7 indexed citations
9.
Ellenberger, David, et al.. (2021). Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care. Multiple Sclerosis Journal. 27(12). 1852–1863. 19 indexed citations
10.
Frahm, Niklas, Jörg Bätzing, David Ellenberger, et al.. (2021). Prevalence of pediatric multiple sclerosis in Germany: A nationwide population‐based analysis. European Journal of Neurology. 28(9). 3173–3176. 6 indexed citations
11.
Ellenberger, David, Peter Flachenecker, Tim Friede, et al.. (2021). Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry. Scientific Reports. 11(1). 13340–13340. 30 indexed citations
12.
Frahm, Niklas, et al.. (2020). The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis. Therapeutic Advances in Neurological Disorders. 13. 1279191069–1279191069. 11 indexed citations
13.
Frahm, Niklas, Michael Hecker, & Uwe K. Zettl. (2020). Polypharmacy among patients with multiple sclerosis: a qualitative systematic review. Expert Opinion on Drug Safety. 19(2). 139–145. 37 indexed citations
14.
Abdelhak, Ahmed, André Huss, Alexander Stahmann, et al.. (2020). Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study. Contemporary Clinical Trials Communications. 18. 100574–100574. 5 indexed citations
15.
Frahm, Niklas, Michael Hecker, & Uwe K. Zettl. (2019). Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors. Scientific Reports. 9(1). 3743–3743. 28 indexed citations
16.
Frahm, Niklas, Michael Hecker, & Uwe K. Zettl. (2019). Polypharmacy in patients with multiple sclerosis: a gender-specific analysis. Biology of Sex Differences. 10(1). 27–27. 19 indexed citations
17.
Malhotra, Sunny, Melissa Sorosina, Jordi Río, et al.. (2017). NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients. Multiple Sclerosis Journal. 24(11). 1507–1510. 8 indexed citations
18.
Hecker, Michael, Dirk Koczan, Brit Fitzner, et al.. (2016). High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution. Molecular Neurobiology. 54(7). 5511–5525. 15 indexed citations
19.
Faiss, Jürgen, K. Baum, F. Hoffmann, et al.. (2014). Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study. BMJ Open. 4(4). e004409–e004409. 16 indexed citations
20.
Winkelmann, Alexander, et al.. (2007). Cognitive impairment in multiple sclerosis. Journal of Neurology. 254(S2). II35–II42. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony T. Reder Breakdown of academic impact, for papers by Rogier Q. Hintzen Breakdown of academic impact, for papers by Hayrettin Tumani Breakdown of academic impact, for papers by Jorge Correale Breakdown of academic impact, for papers by María Trojano Breakdown of academic impact, for papers by Luanne M. Metz Breakdown of academic impact, for papers by Bernd C. Kieseier Breakdown of academic impact, for papers by Manuel Comabella Breakdown of academic impact, for papers by Dennis Bourdette Breakdown of academic impact, for papers by Alireza Minagar
Rankless by CCL
2026